{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:25:58Z","timestamp":1783783558363,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-02025-8","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T20:25:19Z","timestamp":1766435119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atrial fibrillation identification in patients with non-alcoholic fatty liver disease: a machine learning model based on immune-inflammatory markers"],"prefix":"10.1186","volume":"18","author":[{"given":"Yao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaXin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"Suppl","key":"2025_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng ML, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(Suppl):S32\u201342.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"2025_CR2","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1016\/S2468-2667(18)30053-7","volume":"3","author":"TLP Health","year":"2018","unstructured":"Health TLP. Tackling obesity seriously: the time has come. Lancet Public Health. 2018;3(4):e153.","journal-title":"Lancet Public Health"},{"issue":"1","key":"2025_CR3","doi-asserted-by":"publisher","first-page":"e16128","DOI":"10.1111\/liv.16218","volume":"45","author":"A Mantovani","year":"2025","unstructured":"Mantovani A, et al. Is associated with an increased Long-Term risk of atrial fibrillation: an updated systematic review and Meta-Analysis. Liver International: Official J Int Association Study Liver. 2025;45(1):e16128.","journal-title":"Liver International: Official J Int Association Study Liver"},{"issue":"Suppl 2","key":"2025_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/dom.14484","volume":"24","author":"CD Byrne","year":"2022","unstructured":"Byrne CD, Targher G. Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. Diabetes Obes Metab. 2022;24(Suppl 2):28\u201343.","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"2025_CR5","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacep.2020.05.023","volume":"6","author":"E Donnellan","year":"2020","unstructured":"Donnellan E, et al. Impact of nonalcoholic fatty liver disease on arrhythmia recurrence following atrial fibrillation ablation. JACC Clin Electrophysiol. 2020;6(10):1278\u201387.","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"2025_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","volume":"79","author":"A Roca-Fernandez","year":"2023","unstructured":"Roca-Fernandez A, et al. Liver disease is a significant risk factor for cardiovascular outcomes - a UK Biobank study. J Hepatol. 2023;79(5):1085\u201395.","journal-title":"J Hepatol"},{"issue":"2","key":"2025_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217\u201321.","journal-title":"Int J Stroke"},{"issue":"16","key":"2025_CR8","doi-asserted-by":"publisher","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","volume":"141","author":"MK Chung","year":"2020","unstructured":"Chung MK, et al. Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association. Circulation. 2020;141(16):e750-72.","journal-title":"Circulation"},{"key":"2025_CR9","doi-asserted-by":"publisher","first-page":"1360974","DOI":"10.3389\/fphar.2024.1360974","volume":"15","author":"B Zhong","year":"2024","unstructured":"Zhong B, et al. Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation. Front Pharmacol. 2024;15:1360974.","journal-title":"Front Pharmacol"},{"key":"2025_CR10","doi-asserted-by":"publisher","first-page":"1337241","DOI":"10.3389\/fimmu.2024.1337241","volume":"15","author":"K Liu","year":"2024","unstructured":"Liu K, et al. Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Front Immunol. 2024;15:1337241.","journal-title":"Front Immunol"},{"key":"2025_CR11","doi-asserted-by":"publisher","first-page":"981196","DOI":"10.3389\/fendo.2022.981196","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease. Front Endocrinol. 2022;13:981196.","journal-title":"Front Endocrinol"},{"key":"2025_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1115031","volume":"14","author":"R Wang","year":"2023","unstructured":"Wang R, et al. The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol. 2023;14:1115031.","journal-title":"Front Immunol"},{"issue":"5","key":"2025_CR13","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s10787-024-01559-z","volume":"32","author":"X Chen","year":"2024","unstructured":"Chen X, Li A, Ma Q. Neutrophil-lymphocyte ratio and systemic immune-inflammation index as predictors of cardiovascular risk and mortality in prediabetes and diabetes: a population-based study. Inflammopharmacology. 2024;32(5):3213\u201327.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"2025_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02721-9","volume":"24","author":"P Qin","year":"2025","unstructured":"Qin P, et al. Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort. Cardiovasc Diabetol. 2025;24(1):162.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2025_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12916-023-02770-5","volume":"21","author":"X Yang","year":"2023","unstructured":"Yang X, et al. Systemic inflammation indicators and risk of incident arrhythmias in 478,524 individuals: evidence from the UK biobank cohort. BMC Med. 2023;21(1):76.","journal-title":"BMC Med"},{"issue":"11","key":"2025_CR16","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.121.319059","volume":"128","author":"Z Chen","year":"2021","unstructured":"Chen Z, et al. Nonalcoholic fatty liver disease: an emerging driver of cardiac arrhythmia. Circ Res. 2021;128(11):1747\u201365.","journal-title":"Circ Res"},{"issue":"1","key":"2025_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener JG, et al. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23(1):40\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2025_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12874-021-01234-9","volume":"21","author":"MAS Mullah","year":"2021","unstructured":"Mullah MAS, Hanley JA, Benedetti A. LASSO type penalized spline regression for binary data. BMC Med Res Methodol. 2021;21(1):83.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2025_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12859-023-05300-5","volume":"24","author":"H Zhou","year":"2023","unstructured":"Zhou H, Xin Y, Li S. A diabetes prediction model based on Boruta feature selection and ensemble learning. BMC Bioinformatics. 2023;24(1):224.","journal-title":"BMC Bioinformatics"},{"key":"2025_CR20","unstructured":"AF Risk Prediction in Patients with NAFLD. https:\/\/yaozhanghospitaly.shinyapps.io\/make_web\/. Accessed 14 September 2025."},{"issue":"7","key":"2025_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, et al. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16(7):411\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2025_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"issue":"1","key":"2025_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","volume":"8","author":"BJJM Brundel","year":"2022","unstructured":"Brundel BJJM, et al. Atrial fibrillation. Nat Rev Dis Primers. 2022;8(1):21.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"2025_CR24","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/liv.14461","volume":"40","author":"X Cai","year":"2020","unstructured":"Cai X, et al. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation. Liver Int. 2020;40(7):1594\u2013600.","journal-title":"Liver Int"},{"issue":"2","key":"2025_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/liv.14236","volume":"40","author":"J Roh","year":"2020","unstructured":"Roh J, et al. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults. Liver Int. 2020;40(2):338\u201346.","journal-title":"Liver Int"},{"key":"2025_CR26","doi-asserted-by":"publisher","first-page":"1058779","DOI":"10.3389\/fimmu.2022.1058779","volume":"13","author":"Y Song","year":"2022","unstructured":"Song Y, et al. Systemic immune-inflammation index is associated with hepatic steatosis: evidence from NHANES 2015\u20132018. Front Immunol. 2022;13:1058779.","journal-title":"Front Immunol"},{"key":"2025_CR27","doi-asserted-by":"publisher","first-page":"1323174","DOI":"10.3389\/fimmu.2024.1323174","volume":"15","author":"R Ma","year":"2024","unstructured":"Ma R, et al. Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES. Front Immunol. 2024;15:1323174.","journal-title":"Front Immunol"},{"key":"2025_CR28","doi-asserted-by":"publisher","first-page":"1512621","DOI":"10.3389\/fendo.2025.1512621","volume":"16","author":"J He","year":"2025","unstructured":"He J, Yang Y. Association between neutrophil-lymphocyte ratio and all-cause and cardiovascular mortality in patients with diabetes or prediabetes with comorbid obstructive sleep apnea symptoms: evidence from NHANES 2005\u20132008 and 2015\u20132018. Front Endocrinol. 2025;16:1512621.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2025_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02090-6","volume":"18","author":"P Gong","year":"2021","unstructured":"Gong P, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation. 2021;18(1):51.","journal-title":"J Neuroinflammation"},{"key":"2025_CR30","doi-asserted-by":"publisher","first-page":"120495","DOI":"10.1016\/j.atherosclerosis.2025.120495","volume":"409","author":"C Ratti","year":"2025","unstructured":"Ratti C, et al. Understanding MASLD - from molecular pathogenesis to cardiovascular risk: a concise review for the clinical cardiologist. Atherosclerosis. 2025;409:120495.","journal-title":"Atherosclerosis"},{"issue":"9","key":"2025_CR31","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69(9):1691\u2013705.","journal-title":"Gut"},{"issue":"10","key":"2025_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101171","volume":"6","author":"J Boeckmans","year":"2024","unstructured":"Boeckmans J, et al. Inflammation in liver fibrosis and atrial fibrillation: a prospective population-based proteomic study. JHEP Rep. 2024;6(10):101171.","journal-title":"JHEP Rep"},{"issue":"6","key":"2025_CR33","doi-asserted-by":"publisher","first-page":"106147","DOI":"10.4330\/wjc.v17.i6.106147","volume":"17","author":"IS Bharaj","year":"2025","unstructured":"Bharaj IS, et al. Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: a review of pathogenesis. World J Cardiol. 2025;17(6):106147.","journal-title":"World J Cardiol"},{"issue":"1","key":"2025_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44884-z","volume":"13","author":"K Wu","year":"2023","unstructured":"Wu K, et al. Exploring immune related gene signatures and mechanisms linking non alcoholic fatty liver disease to atrial fibrillation through transcriptome data analysis. Sci Rep. 2023;13(1):17548.","journal-title":"Sci Rep"},{"issue":"6","key":"2025_CR35","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353.","journal-title":"Gut"},{"issue":"1","key":"2025_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-017-0604-9","volume":"16","author":"BS Karam","year":"2017","unstructured":"Karam BS, et al. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120.","journal-title":"Cardiovasc Diabetol"},{"key":"2025_CR37","doi-asserted-by":"crossref","unstructured":"Zhang Z, et al. Nonlinear relationship and predictive value of systemic immune-inflammation index for atrial fibrillation recurrence after catheter ablation in hypertensive patients. Heart Rhythm. 2025;22(9):2257\u201368.","DOI":"10.1016\/j.hrthm.2025.03.1958"},{"key":"2025_CR38","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.2147\/JIR.S440722","volume":"16","author":"W Huang","year":"2023","unstructured":"Huang W, et al. Platelet-to-Lymphocyte ratio improves the predictive ability of the risk score for atrial fibrillation recurrence after radiofrequency ablation. J Inflamm Res. 2023;16:6023\u201338.","journal-title":"J Inflamm Res"},{"issue":"8","key":"2025_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.18087\/cardio.2023.8.n2336","volume":"63","author":"\u00d6 Kutlay","year":"2023","unstructured":"Kutlay \u00d6, Yal\u0131m Z, Aktan AK. Inflammatory biomarkers derived from whole blood cell count in atrial fibrillation patients. Kardiologiia. 2023;63(8):50\u20135.","journal-title":"Kardiologiia"},{"key":"2025_CR40","doi-asserted-by":"publisher","first-page":"1127425","DOI":"10.3389\/fendo.2023.1127425","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, et al. The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: a propensity-matched analysis. Front Endocrinol. 2023;14:1127425.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2025_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12944-025-02484-y","volume":"24","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, et al. Association between monocyte-high-density lipoprotein cholesterol ratio and mortality in a population with asthma: a cohort study. Lipids Health Dis. 2025;24(1):59.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2025_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12877-025-06120-3","volume":"25","author":"S Zhang","year":"2025","unstructured":"Zhang S, et al. The association between inflammatory, metabolic, and hepatic fibrosis-related biomarkers and atrial fibrillation in older patients with metabolic dysfunction-associated steatotic liver disease. BMC Geriatr. 2025;25(1):459.","journal-title":"BMC Geriatr"},{"issue":"3","key":"2025_CR43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11883-007-0026-3","volume":"9","author":"M Navab","year":"2007","unstructured":"Navab M, et al. High-density lipoprotein: antioxidant and anti-inflammatory properties. Curr Atheroscler Rep. 2007;9(3):244\u20138.","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"2025_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001211","volume":"3","author":"A Alonso","year":"2014","unstructured":"Alonso A, et al. Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study. J Am Heart Assoc. 2014;3(5):e001211.","journal-title":"J Am Heart Assoc"},{"key":"2025_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.12659\/MSMBR.902557","volume":"23","author":"A Weymann","year":"2017","unstructured":"Weymann A, et al. Platelets cellular and functional characteristics in patients with atrial fibrillation: a comprehensive meta-analysis and systematic review. Med Sci Monit Basic Res. 2017;23:58\u201386.","journal-title":"Med Sci Monit Basic Res"},{"issue":"36","key":"2025_CR46","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1093\/eurheartj\/ehad375","volume":"44","author":"L Segan","year":"2023","unstructured":"Segan L, et al. New-onset atrial fibrillation prediction: the HARMS2-AF risk score. Eur Heart J. 2023;44(36):3443\u201352.","journal-title":"Eur Heart J"},{"key":"2025_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1123493","volume":"13","author":"L Lei","year":"2023","unstructured":"Lei L, et al. Dictionary learning LASSO for feature selection with application to hepatocellular carcinoma grading using contrast enhanced magnetic resonance imaging. Front Oncol. 2023;13:1123493.","journal-title":"Front Oncol"},{"issue":"1","key":"2025_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10238-025-01701-3","volume":"25","author":"Y Fu","year":"2025","unstructured":"Fu Y, Zhao J, Wang Y. LASSO regression and Boruta algorithm to explore the relationship between neutrophil percentage to albumin ratio and asthma: results from the NHANES 2001 to 2018. Clin Exp Med. 2025;25(1):149.","journal-title":"Clin Exp Med"},{"key":"2025_CR49","doi-asserted-by":"publisher","first-page":"110528","DOI":"10.1016\/j.compbiomed.2025.110528","volume":"195","author":"MF Sultan","year":"2025","unstructured":"Sultan MF, Karim T, Hossain SM, et al. BitterEN: A novel ensemble model for the identification of bitter peptide. Comput Biol Med. 2025;195:110528.","journal-title":"Comput Biol Med"},{"key":"2025_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107915","volume":"169","author":"T Karim","year":"2024","unstructured":"Karim T, Shaon M, Sultan MF, Hasan MZ, Kafy AA. ANNprob-ACPs: a novel anticancer peptide identifier based on probabilistic feature fusion approach. Comput Biol Med. 2024;169:107915.","journal-title":"Comput Biol Med"},{"issue":"18","key":"2025_CR51","doi-asserted-by":"publisher","first-page":"e37820","DOI":"10.1016\/j.heliyon.2024.e37820","volume":"10","author":"MF Sultan","year":"2024","unstructured":"Sultan MF, Shaon M, Karim T, et al. MLAFP-XN: leveraging neural network model for development of antifungal peptide identification tool. Heliyon. 2024;10(18):e37820.","journal-title":"Heliyon"},{"key":"2025_CR52","doi-asserted-by":"publisher","first-page":"115828","DOI":"10.1016\/j.ab.2025.115828","volume":"702","author":"MF Sultan","year":"2025","unstructured":"Sultan MF, Karim T, Hossain SM, et al. DHUpredET: A comparative computational approach for identification of dihydrouridine modification sites in RNA sequence. Anal Biochem. 2025;702:115828.","journal-title":"Anal Biochem"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-02025-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:03:03Z","timestamp":1769443383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-025-02025-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-02025-8","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of The Affiliated Hospital of Northwest University \u00b7 Xi\u2019an No.3 Hospital which waived the need for written informed consent due to the retrospective study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}